Supporting this hypothesis, we found that G-CIMP+ Ink4a-Arf−/− EGFRvIII glioblastomas were more resistant to EGFR inhibition than their isogenic G-CIMP- counterparts. Here, CDKN2A is linked to glioblastoma.